Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-01 Sale | 2022-03-02 8:40 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $17.59 | $175,900 | 609,864 (Direct) | View |
| 2022-02-01 Sale | 2022-02-03 7:12 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $17.56 | $175,600 | 619,864 (Direct) | View |
| 2022-01-14 Sale | 2022-01-18 9:48 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 9,700 | $22.03 | $213,691 | 317,606 (Direct) | View |
| 2022-01-10 Sale | 2022-01-11 9:40 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $19.55 | $195,500 | 619,864 (Direct) | View |
| 2021-12-21 Sale | 2021-12-23 9:03 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 100 | $22 | $2,200 | 327,306 (Direct) | View |
| 2021-12-17 Sale | 2021-12-20 4:54 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 3,200 | $22.04 | $70,528 | 327,406 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 5:20 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 17,500 | $20.18 | $353,150 | 255,996 (Direct) | View |
| 2021-11-03 Sale | 2021-11-05 4:17 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 25,000 | $24.28 | $607,123 | 195,510 (Indirect Direct) | View |
| 2021-11-02 Sale | 2021-11-03 4:16 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 17,500 | $22.57 | $394,975 | 273,496 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:15 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $22.24 | $144,560 | 330,606 (Direct) | View |
| 2021-10-15 Sale | 2021-10-18 4:21 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 12,500 | $21.59 | $269,826 | 120,921 (Direct) | View |
| 2021-10-04 Sale | 2021-10-05 4:11 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 17,500 | $21.54 | $376,950 | 290,996 (Direct) | View |
| 2021-10-01 Sale | 2021-10-05 4:10 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $22.06 | $143,367 | 337,106 (Direct) | View |
| 2021-09-15 Sale | 2021-09-17 4:05 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 12,500 | $24.69 | $308,605 | 133,421 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 4:38 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 12,500 | $24.04 | $300,500 | 220,510 (Indirect Direct) | View |
| 2021-09-01 Sale | 2021-09-03 4:38 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 8,559 | $24 | $205,416 | 343,606 (Direct) | View |
| 2021-09-02 Sale | 2021-09-03 4:37 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 17,500 | $23.89 | $418,075 | 308,496 (Direct) | View |
| 2021-08-16 Sale | 2021-08-17 9:15 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $18.79 | $187,900 | 145,921 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 5:39 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,441 | $22.03 | $97,835 | 352,165 (Direct) | View |
| 2021-08-03 Sale | 2021-08-04 5:38 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 17,500 | $20.83 | $364,577 | 325,996 (Direct) | View |
| 2021-07-15 Sale | 2021-07-19 4:43 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 10,000 | $20.9 | $209,044 | 155,921 (Direct) | View |
| 2021-07-06 Sale | 2021-07-08 7:19 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $24.52 | $159,380 | 356,606 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-02 Option Award | 2022-06-03 4:25 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:06 pm | N/A 2032-06-01 | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 8:40 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0 | 609,864 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 8:40 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0.615 | 609,864 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 7:12 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0 | 619,864 (Direct) | View |
| 2022-02-01 Exercise | 2022-02-03 7:12 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0.615 | 619,864 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-18 9:48 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 9,700 | $0 | 317,606 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-18 9:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 9,700 | $7.009 | 317,606 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-11 9:40 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0 | 619,864 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-11 9:40 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,000 | $0.615 | 619,864 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-11 4:40 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 27,744 | $0 | 316,074 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-11 4:40 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 27,744 | $0.615 | 316,074 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 9:21 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 53,000 | $0 | 514,708 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-04 9:21 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 53,000 | $0.615 | 514,708 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 9:03 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 100 | $0 | 327,306 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 9:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 100 | $7.009 | 327,306 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 4:54 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 3,200 | $0 | 327,406 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 4:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 3,200 | $7.009 | 327,406 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:15 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 261,662 | $0 | 261,662 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:08 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 87,221 | $0 | 87,221 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:08 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 87,221 | $0 | 87,221 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:07 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 87,221 | $0 | 87,221 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:06 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 87,221 | $0 | 87,221 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:15 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $0 | 330,606 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:15 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $7.009 | 330,606 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 4:10 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $0 | 337,106 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 4:10 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $7.009 | 337,106 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:38 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 8,559 | $0 | 343,606 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:38 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 8,559 | $7.009 | 343,606 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 5:39 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,441 | $0 | 352,165 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 5:39 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,441 | $7.009 | 352,165 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 9,000 | $0 | 259,306 (Direct) | View |
| 2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 9,000 | $0.615 | 259,306 (Direct) | View |
| 2021-07-12 Option Award | 2021-07-14 4:09 pm | N/A 2031-07-12 | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 7:19 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $0 | 356,606 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 7:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 6,500 | $7.009 | 356,606 (Direct) | View |